Skip to main content
Clinical Trials/NCT02440555
NCT02440555
Completed
Not Applicable

Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose Compared to Current Screening in the Priority Health Area of Saint-Etienne and the Sainté Diabète Network.

Centre Hospitalier Universitaire de Saint Etienne1 site in 1 country1,305 target enrollmentNovember 2014
ConditionsType 2 Diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Enrollment
1305
Locations
1
Primary Endpoint
Sensitivity of detection of type 2 diabetes
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Type 2 diabetes is the chronic disease with the most important development in France, and particularly in the Saint-Etienne area due to his specific population.

Different studies showed the interest of screening targeted on high risk population to reduce cardiovascular risks and mortality.

The current screening recommandation is an opportunist targeted screening on population older than 45 years with risk factors by a fasting glucose every 3 years, and a communautaire screening targeted on population older than 45 years suffering precarity with or without risk factors by capillary blood glucose or fasting glucose.

The objective of the Sainté Diabete network is to optimize the screening of diabetics, their follow-up and their treatments. Using a self-administered questionnaire during a medical visit could be a simple, cheap and efficient tool to detect diabetics as soon as possible.

Registry
clinicaltrials.gov
Start Date
November 2014
End Date
March 2015
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Man or woman
  • 45 years or older
  • Signed informed consent

Exclusion Criteria

  • fasting glucose performed in the last 2 years
  • diabetes history
  • not living in Saint-Etienne

Outcomes

Primary Outcomes

Sensitivity of detection of type 2 diabetes

Time Frame: Day 1 (inclusion day)

To evaluate the sensitivity (true positive) of detection of type 2 diabetes by a self-administered questionnaire performed in a pharmacy or a hospital compared to capillary blood glucose measurements in the same population from the priority health area of Saint-Etienne.

Secondary Outcomes

  • To evaluate the numbers of patients screened by self-administered questionnaire and diagnosed as diabetics using fasting glucose.(Month 2)
  • To evaluate the cost of the targeted screening and the screening accessibility to population from the priority health area of Saint-Etienne(Month 2)
  • Specificity of detection of type 2 diabetes(Day 1 (inclusion day))

Study Sites (1)

Loading locations...

Similar Trials